Qing Li Selected Research

Qing Li Research Topics

Disease

446	Neoplasms (Cancer) 10/2022 - 09/2002
144	Breast Neoplasms (Breast Cancer) 07/2022 - 05/2006
86	Inflammation (Inflammations) 10/2022 - 07/2003
85	Neoplasm Metastasis (Metastasis) 10/2022 - 12/2007
63	Infections 04/2022 - 10/2002
52	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2002
39	Stomach Neoplasms (Stomach Cancer) 01/2022 - 12/2002
38	Carcinogenesis 04/2022 - 01/2006
33	Fibrosis (Cirrhosis) 12/2021 - 03/2004
31	Wounds and Injuries (Trauma) 01/2022 - 10/2003
30	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 03/2010
29	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 12/2007
29	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2007
28	Pain (Aches) 07/2022 - 08/2002
28	Reperfusion Injury 03/2022 - 03/2008
27	Lung Neoplasms (Lung Cancer) 05/2022 - 09/2007
27	Triple Negative Breast Neoplasms 01/2022 - 06/2012
26	Atherosclerosis 01/2022 - 11/2008
25	Alzheimer Disease (Alzheimer's Disease) 09/2020 - 07/2008
23	Leukemia 11/2022 - 12/2010
23	Hypoxia (Hypoxemia) 07/2022 - 04/2010
22	Insulin Resistance 08/2022 - 01/2004
22	Ischemia 01/2022 - 09/2002
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 01/2012
18	Liver Neoplasms (Liver Cancer) 07/2022 - 12/2002
18	Carcinoma (Carcinomatosis) 01/2022 - 09/2002
18	Myocardial Infarction 01/2021 - 06/2007
17	Glioma (Gliomas) 01/2022 - 03/2003
17	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2010
17	Body Weight (Weight, Body) 09/2021 - 04/2005
16	Cognitive Dysfunction 01/2022 - 04/2012
16	Obesity 07/2021 - 04/2005
16	Non-alcoholic Fatty Liver Disease 02/2021 - 05/2011
14	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 05/2013
14	Infarction (Infarctions) 01/2022 - 04/2008
13	COVID-19 10/2022 - 01/2020
13	Necrosis 07/2022 - 09/2002
13	Pancreatic Neoplasms (Pancreatic Cancer) 05/2022 - 07/2009
13	Lymphatic Metastasis 01/2022 - 03/2013
13	Adenocarcinoma 01/2022 - 11/2009
13	Disease Progression 10/2021 - 01/2010
13	Fatigue 07/2021 - 09/2011
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2021 - 12/2006
13	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021 - 06/2005
13	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 10/2009

Drug/Important Bio-Agent (IBA)

152	Proteins (Proteins, Gene)FDA Link 08/2022 - 09/2002
104	Biomarkers (Surrogate Marker)IBA 11/2022 - 07/2002
65	Pharmaceutical PreparationsIBA 10/2022 - 03/2005
62	MicroRNAs (MicroRNA)IBA 03/2022 - 03/2010
55	Biological ProductsIBA 07/2021 - 09/2002
39	CytokinesIBA 10/2022 - 04/2010
38	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 06/2003
35	Messenger RNA (mRNA)IBA 01/2022 - 06/2005
34	Therapeutic UsesIBA 10/2022 - 03/2004
34	Long Noncoding RNAIBA 06/2022 - 04/2014
32	LipidsIBA 10/2022 - 01/2003
32	Hormones (Hormone)IBA 06/2022 - 05/2006
30	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 09/2003
28	Indicators and Reagents (Reagents)IBA 06/2022 - 10/2007
27	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2006
27	AntigensIBA 01/2022 - 08/2002
26	EnzymesIBA 09/2022 - 01/2005
25	Insulin (Novolin)FDA Link 08/2022 - 04/2005
25	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2022 - 09/2007
23	Interleukin-6 (Interleukin 6)IBA 03/2022 - 08/2005
22	AntibodiesIBA 05/2022 - 07/2005
22	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2012
21	Peptides (Polypeptides)IBA 01/2022 - 01/2005
20	Phosphotransferases (Kinase)IBA 02/2022 - 09/2002
18	LigandsIBA 01/2022 - 02/2009
18	CholesterolIBA 01/2022 - 03/2010
17	Small Interfering RNA (siRNA)IBA 01/2022 - 08/2010
17	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 10/2006
17	VaccinesIBA 01/2022 - 07/2002
16	Transcription Factors (Transcription Factor)IBA 01/2022 - 04/2010
16	CateninsIBA 12/2021 - 03/2016
15	AnthracyclinesIBA 01/2022 - 01/2010
15	Monoclonal AntibodiesIBA 01/2021 - 08/2002
14	Estrogen ReceptorsIBA 01/2022 - 01/2011
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 08/2005
13	Retinaldehyde (Retinal)IBA 04/2022 - 09/2002
13	Immune Checkpoint InhibitorsIBA 02/2022 - 01/2018
13	Chimeric Antigen ReceptorsIBA 02/2022 - 05/2014
13	oxidized low density lipoproteinIBA 01/2022 - 04/2005
13	AlbuminsIBA 01/2022 - 05/2007
13	Caspase 3 (Caspase-3)IBA 01/2022 - 04/2008
13	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2008
13	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2021 - 09/2009
13	human ERBB2 proteinIBA 02/2021 - 12/2011
13	Blood Glucose (Blood Sugar)IBA 01/2019 - 11/2008
12	ChromatinIBA 11/2022 - 07/2008
12	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2022 - 09/2007

Therapy/Procedure

206	Therapeutics 11/2022 - 06/2003
75	Drug Therapy (Chemotherapy) 06/2022 - 09/2003
38	Immunotherapy 08/2022 - 03/2003
26	Chinese Traditional Medicine (Traditional Chinese Medicine) 10/2022 - 06/2012
21	Transplantation 01/2022 - 05/2007
16	Radiotherapy 10/2021 - 02/2007
14	Neoadjuvant Therapy 01/2022 - 02/2012
13	Adjuvant Chemotherapy 01/2022 - 01/2008